The first 3L microcollagen technology with a blend of PDLLA+HA.
What is PDLLA?
PLA (Poly Lactic Acid) is a biomaterial made by polymerising lactic acid obtained from fermentation of agricultural products such as corn or potatoes.
PLA is approved by the US FDA and European regulatory authorities for dissolvable medical materials such as surgical sutures and orthopaedic implants.
PDLLA is the safest and most biocompatible isomer of PLA, and due to its unique structure, it can stimulate collagen autogenesis in the safest manner.
Non-Cross linked HA is highly compatible with the body, providing immediate filler and hydration.
Juvelook Facial Needle / Lenisna Facial Needle
3L Microcollagen Technology
-Light Formula
-Lift & Volume
-Luminous Complexion to brighten the skin.
Description: Juvelook is a hybrid filler which have connected both benefits of immediate filling efect of HA (hyaluronic acid) and long-term stimulation of collagen production by PDLLA (Poly D,L - lactide).
Thanks to the patented manufacturing technology, patent no. 10-1481441, no. 10-1725279, a preparation with unique properties has been created: long-lasting effectiveness and an increased safety profile.
JUVELOOK is a time-active hybrid filler with a concentration of 42.5 mg of poly D,L lactide and 7.5 mg of non-cross-linked hyaluronic acid.
Advantage:
the only one in the world polylactic acid for use in the eye area, mesotherapy of the face, neck and neckline
its ability to stimulate collagen production in the strongest way and restore youthful appearance in a gradual and natural way.
no need to massage the post-treatment areas due to the round shape of PDLLA acid molecules and its combination with non-cross-linked hyaluronic acid.
the durability of the treatment lasts over 24 months from the last treatment. The effect can be sustained by performing 1 reminder treatment after 24 months.
Effect The effects of the therapy are visible immediately after injection. We obtain a filling effect thanks to the presence of hyaluronic acid. After about 2 weeks, the production of collagen is initiated by the presence of PDLLA lactic acid microparticles. The effects of the therapy last for over two years after the last treatment. The recommended number of treatments is 2 or 3, depending on the skin deficiency, at intervals of 6-8 weeks. After two years, we recommend performing 1 reminder treatment